These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24900436)

  • 1. Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.
    Munchhof MJ; Li Q; Shavnya A; Borzillo GV; Boyden TL; Jones CS; LaGreca SD; Martinez-Alsina L; Patel N; Pelletier K; Reiter LA; Robbins MD; Tkalcevic GT
    ACS Med Chem Lett; 2012 Feb; 3(2):106-11. PubMed ID: 24900436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydroimid azo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 1.
    Malancona S; Altamura S; Filocamo G; Kinzel O; Hernando JI; Rowley M; Scarpelli R; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4422-8. PubMed ID: 21737272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a potent antagonist of smoothened in hedgehog signaling.
    Fan J; Li H; Kuang L; Zhao Z; He W; Liu C; Wang Y; Cheng SY; Chen W
    Cell Biosci; 2021 Mar; 11(1):46. PubMed ID: 33653381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist.
    Pan S; Wu X; Jiang J; Gao W; Wan Y; Cheng D; Han D; Liu J; Englund NP; Wang Y; Peukert S; Miller-Moslin K; Yuan J; Guo R; Matsumoto M; Vattay A; Jiang Y; Tsao J; Sun F; Pferdekamper AC; Dodd S; Tuntland T; Maniara W; Kelleher JF; Yao YM; Warmuth M; Williams J; Dorsch M
    ACS Med Chem Lett; 2010 Jun; 1(3):130-4. PubMed ID: 24900187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
    Ott GR; Asakawa N; Lu Z; Anand R; Liu RQ; Covington MB; Vaddi K; Qian M; Newton RC; Christ DD; Trzaskos JM; Duan JJ
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1577-82. PubMed ID: 18242982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists.
    Muraglia E; Ontoria JM; Branca D; Dessole G; Bresciani A; Fonsi M; Giuliano C; Llauger Bufi L; Monteagudo E; Palumbi MC; Torrisi C; Rowley M; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5283-8. PubMed ID: 21802943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood-brain barrier.
    Rohner A; Spilker ME; Lam JL; Pascual B; Bartkowski D; Li QJ; Yang AH; Stevens G; Xu M; Wells PA; Planken S; Nair S; Sun S
    Mol Cancer Ther; 2012 Jan; 11(1):57-65. PubMed ID: 22084163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells.
    Fukushima N; Minami Y; Kakiuchi S; Kuwatsuka Y; Hayakawa F; Jamieson C; Kiyoi H; Naoe T
    Cancer Sci; 2016 Oct; 107(10):1422-1429. PubMed ID: 27461445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a series of 4-[3-(quinolin-2-yl)-1,2,4-oxadiazol-5-yl]piperazinyl ureas as potent smoothened antagonist hedgehog pathway inhibitors.
    Ontoria JM; Bufi LL; Torrisi C; Bresciani A; Giomini C; Rowley M; Serafini S; Bin H; Hao W; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5274-82. PubMed ID: 21803580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.
    Miller-Moslin K; Peukert S; Jain RK; McEwan MA; Karki R; Llamas L; Yusuff N; He F; Li Y; Sun Y; Dai M; Perez L; Michael W; Sheng T; Lei H; Zhang R; Williams J; Bourret A; Ramamurthy A; Yuan J; Guo R; Matsumoto M; Vattay A; Maniara W; Amaral A; Dorsch M; Kelleher JF
    J Med Chem; 2009 Jul; 52(13):3954-68. PubMed ID: 19469545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoothened antagonists: a promising new class of antitumor agents.
    Gallinari P; Filocamo G; Jones P; Pazzaglia S; Steinkühler C
    Expert Opin Drug Discov; 2009 May; 4(5):525-44. PubMed ID: 23485085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of N-[(1-aryl-1H-indazol-5-yl)methyl]amides derivatives as smoothened antagonists for inhibition of the hedgehog pathway.
    Dessole G; Branca D; Ferrigno F; Kinzel O; Muraglia E; Palumbi MC; Rowley M; Serafini S; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4191-5. PubMed ID: 19540115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclo- propyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 2.
    Kinzel O; Alfieri A; Altamura S; Brunetti M; Bufali S; Colaceci F; Ferrigno F; Filocamo G; Fonsi M; Gallinari P; Malancona S; Hernando JI; Monteagudo E; Orsale MV; Palumbi MC; Pucci V; Rowley M; Sasso R; Scarpelli R; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4429-35. PubMed ID: 21737263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of an Atropisomeric PI3Kβ Selective Inhibitor through Optimization of the Hinge Binding Motif.
    Perreault S; Arjmand F; Chandrasekhar J; Hao J; Keegan KS; Koditek D; Lepist EI; Matson CK; McGrath ME; Patel L; Sedillo K; Therrien J; Till NA; Tomkinson A; Treiberg J; Zherebina Y; Phillips G
    ACS Med Chem Lett; 2020 Jun; 11(6):1236-1243. PubMed ID: 32551006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human Smoothened inhibitor PF-04449913 induces exit from quiescence and loss of multipotent Drosophila hematopoietic progenitor cells.
    Giordani G; Barraco M; Giangrande A; Martinelli G; Guadagnuolo V; Simonetti G; Perini G; Bernardoni R
    Oncotarget; 2016 Aug; 7(34):55313-55327. PubMed ID: 27486815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NL-103, a novel dual-targeted inhibitor of histone deacetylases and hedgehog pathway, effectively overcomes vismodegib resistance conferred by Smo mutations.
    Zhao J; Quan H; Xie C; Lou L
    Pharmacol Res Perspect; 2014 Jun; 2(3):e00043. PubMed ID: 25505589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor.
    Quan ML; Lam PY; Han Q; Pinto DJ; He MY; Li R; Ellis CD; Clark CG; Teleha CA; Sun JH; Alexander RS; Bai S; Luettgen JM; Knabb RM; Wong PC; Wexler RR
    J Med Chem; 2005 Mar; 48(6):1729-44. PubMed ID: 15771420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.
    Ma H; Chen Q; Zhu F; Zheng J; Li J; Zhang H; Chen S; Xing H; Luo L; Zheng LT; He S; Zhang X
    Eur J Med Chem; 2018 Apr; 149():110-121. PubMed ID: 29499483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A concise and efficient synthesis of amino-substituted (1H-benzo[d]imidazol-1-yl)pyrimidine hybrids: synthetic sequence and the molecular and supramolecular structures of six examples.
    Vicentes DE; Rodríguez R; Ochoa P; Cobo J; Glidewell C
    Acta Crystallogr C Struct Chem; 2019 Oct; 75(Pt 10):1405-1416. PubMed ID: 31589157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-695735), an orally efficacious inhibitor of insulin-like growth factor-1 receptor kinase with broad spectrum in vivo antitumor activity.
    Velaparthi U; Wittman M; Liu P; Carboni JM; Lee FY; Attar R; Balimane P; Clarke W; Sinz MW; Hurlburt W; Patel K; Discenza L; Kim S; Gottardis M; Greer A; Li A; Saulnier M; Yang Z; Zimmermann K; Trainor G; Vyas D
    J Med Chem; 2008 Oct; 51(19):5897-900. PubMed ID: 18763755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.